Konsyl Daily Fiber Therapy Interactions
There are 33 drugs known to interact with Konsyl Daily Fiber Therapy (polycarbophil), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 7 are moderate, and 26 are minor.
- View all 33 medications that may interact with Konsyl Daily Fiber Therapy
- View Konsyl Daily Fiber Therapy alcohol/food interactions (1)
- View Konsyl Daily Fiber Therapy disease interactions (5)
Most frequently checked interactions
View interaction reports for Konsyl Daily Fiber Therapy (polycarbophil) and the medicines listed below.
- albuterol
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- baclofen
- buspirone
- Claritin (loratadine)
- Colace (docusate)
- ferrous sulfate
- Flonase (fluticasone nasal)
- folic acid
- furosemide
- gabapentin
- ibuprofen
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- magnesium oxide
- melatonin
- meloxicam
- metformin
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- omeprazole
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- rosuvastatin
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
Konsyl Daily Fiber Therapy alcohol/food interactions
There is 1 alcohol/food interaction with Konsyl Daily Fiber Therapy (polycarbophil).
Konsyl Daily Fiber Therapy disease interactions
There are 5 disease interactions with Konsyl Daily Fiber Therapy (polycarbophil) which include:
- intestinal obstruction
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- hypercalcemia
Report options
QR code containing a link to this page
More about Konsyl Daily Fiber Therapy (polycarbophil)
- Konsyl Daily Fiber Therapy consumer information
- Compare alternatives
- Drug images
- Side effects
- Drug class: laxatives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
